Clinuvel Pharmaceuticals (CUV) Ownership - Who Owns Clinuvel Pharmaceuticals ?

Q: What percentage of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by retail investors?

According to the latest TipRanks data, approximately 95.44% of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by retail investors.

Q: Who owns the most shares of Clinuvel Pharmaceuticals Limited (AU:CUV)?

Vanguard owns the most shares of Clinuvel Pharmaceuticals Limited (AU:CUV).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

106 Followers

Clinuvel Pharmaceuticals (CUV) Ownership Overview

2.81%

Mutual Funds

1.75% ETFs

95.44% Public Companies and

Individual Investors

The ownership structure of Clinuvel Pharmaceuticals (AU:CUV) stock is a mix of institutional, retail, and individual investors. , and 95.44% is owned by Public Companies and Individual Investors.

The ownership structure of Clinuvel Pharmaceuticals (AU:CUV) stock is a mix of institutional, retail, and individual investors. Approximately 97.19% of the company’s stock is owned by Institutional Investors, 2.81% is owned by Insiders

Top Shareholders

# of Shares	Type	% Holding	Value
604,448	Institution	1.20%	4,124,753
596,269	Institution	1.19%	4,068,940
385,068	Institution	0.77%	2,627,704
229,891	Institution	0.46%	1,568,776
174,764	Institution	0.35%	1,192,590
125,035	Institution	0.25%	853,239
87,129	Institution	0.17%	594,568
40,326	Institution	0.08%	275,185
17,792	Institution	0.04%	121,413
17,080	Institution	0.03%	116,554

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
596,269	Institution	1.19%	4,068,940
385,068	Institution	0.77%	2,627,704
229,891	Institution	0.46%	1,568,776
174,764	Institution	0.35%	1,192,590
17,080	Institution	0.03%	116,554
5,000	Institution	<0.01%	34,120
2,335	Institution	<0.01%	15,934
1	Institution	<0.01%	7

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard FTSE Developed Markets ETF	385,068	Institution	0.77%	2,740,194
Vanguard FTSE All-World ex-US Small-Cap ETF	154,860	Institution	0.31%	1,102,004
Schwab International Small-Cap Equity ETF	87,129	Institution	0.17%	588,987
Dimensional International Small Cap ETF	67,950	Institution	0.14%	463,394
Vanguard FTSE Pacific ETF	52,162	Institution	0.10%	371,192
Dimensional International Core Equity 2 ETF	31,859	Institution	0.06%	217,267
Dimensional International Core Equity Market ETF	24,712	Institution	0.05%	167,051
SPDR S&P International Small Cap ETF	23,189	Institution	0.05%	156,756
iShares MSCI Intl Small-Cap Multifactor ETF	17,792	Institution	0.04%	120,050
SPDR Portfolio Developed World ex-US ETF	17,137	Institution	0.03%	115,845

FAQ

Who Owns Clinuvel Pharmaceuticals Limited (AU:CUV)?

Currently, no data Available

What percentage of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by institutional investors?

Currently, no data Available

What percentage of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by retail investors?

According to the latest TipRanks data, approximately 95.44% of Clinuvel Pharmaceuticals Limited (AU:CUV) stock is held by retail investors.

Who owns the most shares of Clinuvel Pharmaceuticals Limited (AU:CUV)?

Vanguard owns the most shares of Clinuvel Pharmaceuticals Limited (AU:CUV).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.